De Novo Variants in the F-Box Protein FBXO11 in 20 Individuals with a Variable Neurodevelopmental Disorder

Beitrag in einer Fachzeitschrift

Details zur Publikation

Autorinnen und Autoren: Gregor A, Sadleir LG, Asadollahi R, Azzarello-Burri S, Battaglia A, Ousager LB, Boonsawat P, Bruel AL, Buchert R, Calpena E, Cogne B, Dallapiccola B, Distelmaier F, Elmslie F, Faivre L, Haack TB, Harrison V, Henderson A, Hunt D, Isidor B, Joset P, Kumada S, Lachmeijer AMA, Lees M, Lynch SA, Martinez F, Matsumoto N, Mcdougall C, Mefford HC, Miyake N, Myers CT, Moutton S, Nesbitt A, Novelli A, Orellana C, Rauch A, Rosello M, Saida K, Santani AB, Sarkar A, Scheffer IE, Shinawi M, Steindl K, Symonds JD, Zackai EH, Univ WCMGDDD, Reis A, Sticht H, Zweier C
Zeitschrift: American Journal of Human Genetics
Jahr der Veröffentlichung: 2018
Band: 103
Heftnummer: 2
Seitenbereich: 305-316
ISSN: 0002-9297


Next-generation sequencing combined with international data sharing has enormously facilitated identification of new disease-associated genes and mutations. This is particularly true for genetically extremely heterogeneous entities such as neurodevelopmental disorders (NDDs). Through exome sequencing and world-wide collaborations, we identified and assembled 20 individuals with de novo variants in FBXO11. They present with mild to severe developmental delay associated with a range of features including short (4/20) or tall (2/20) stature, obesity (5/20), microcephaly (4/19) or macrocephaly (2/19), behavioral problems (17/20), seizures (5/20), cleft lip or palate or bifid uvula (3/20), and minor skeletal anomalies. FBXO11 encodes a member of the F-Box protein family, constituting a subunit of an E3-ubiquitin ligase complex. This complex is involved in ubiquitination and proteasomal degradation and thus in controlling critical biological processes by regulating protein turnover. The identified de novo aberrations comprise two large deletions, ten likely gene disrupting variants, and eight missense variants distributed throughout FBXO11. Structural modeling for missense variants located in the CASH or the Zinc-finger UBR domains suggests destabilization of the protein. This, in combination with the observed spectrum and localization of identified variants and the lack of apparent genotype-phenotype correlations, is compatible with loss of function or haploinsufficiency as an underlying mechanism. We implicate de novo missense and likely gene disrupting variants in FBXO11 in a neurodevelopmental disorder with variable intellectual disability and various other features.

FAU-Autorinnen und Autoren / FAU-Herausgeberinnen und Herausgeber

Gregor, Anne Dr. rer. nat.
Humangenetisches Institut
Sticht, Heinrich Prof. Dr.
Professur für Bioinformatik
Zweier, Christiane Prof. Dr.
Medizinische Fakultät

Einrichtungen weiterer Autorinnen und Autoren

Children's Hospital of Philadelphia
Eberhard Karls Universität Tübingen
Great Ormond Street Hospital (GOSH)
Heinrich-Heine-Universität Düsseldorf
Hospital Universitario y Politécnico de La Fe
IRCCS Fondazione Stella Maris
Istituto di ricovero e cura a carattere scientifico (IRCCS)
Nantes University Hospital / Centre hospitalier universitaire de Nantes (CHU)
Newcastle upon Tyne Hospitals NHS Foundation Trust
Nottingham University Hospitals
Odense Universitetshospital (OUH)
Princess Anne Hospital
Royal Hospital for Children
St George's, University of London (SGUL) / St George's Hospital Medical School
Temple Street Children's University Hospital
The University of Melbourne
Tokyo Metropolitan Institute of Medical Science
Universität Zürich (UZH)
University Medical Centre Utrecht (UMC Utrecht)
University of Burgundy
University of Otago
University of Oxford
University of Washington
Wellcome Trust Sanger Institute - Genome Research Limited
Yokohama City University


Gregor, A., Sadleir, L.G., Asadollahi, R., Azzarello-Burri, S., Battaglia, A., Ousager, L.B.,... Zweier, C. (2018). De Novo Variants in the F-Box Protein FBXO11 in 20 Individuals with a Variable Neurodevelopmental Disorder. American Journal of Human Genetics, 103(2), 305-316.

Gregor, Anne, et al. "De Novo Variants in the F-Box Protein FBXO11 in 20 Individuals with a Variable Neurodevelopmental Disorder." American Journal of Human Genetics 103.2 (2018): 305-316.


Zuletzt aktualisiert 2019-16-01 um 06:02